Follow the people · Insider
Joel S. Marcus
Joel S. Marcus files insider transactions with the SEC as an executive chairman of Alexandria Real Estate Equities (ARE). We hold 5 disclosed purchases and sales filed since 23 January 2006, 1 of them in the last 90 days.
- Files forARE
- Disclosed buys and sells5 in all, 1 in the last 90 days
- Last disclosure19 August 2026
Positions held
10 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 24 May 2006 — 17 August 2026Executive Chairman · Alexandria Real Estate Equities (ARE)265 Form 4 lines · source: SEC Form 4
- Filed 30 June 2014 — 2 April 2025Director · Intra-Cellular Therapies (ITCI)100 Form 4 lines · source: SEC Form 4
- Filed 13 May 2019 — 6 June 2024Director · Applied Therapeutics (APLT)50 Form 4 lines · source: SEC Form 4
- Filed 7 October 2019 — 17 August 2022Director · Frequency Therapeutics (FREQ)31 Form 4 lines · source: SEC Form 4
- Filed 19 June 2019 — 7 June 2022Director · MeiraGTx Holdings (MGTX)14 Form 4 lines · source: SEC Form 4
- Filed 21 October 2014 — 15 March 2019Director · Atara Biotherapeutics (ATRA)29 Form 4 lines · source: SEC Form 4
- Filed 23 March 2005 — 6 May 2016Chief Executive Officer · Alexandria Real Estate Equities (are)40 Form 4 lines · source: SEC Form 4
- Filed 30 May 2014 — 30 May 2014Director · Rexford Industrial Realty (NYSE: REXR)1 Form 4 line · source: SEC Form 4
- Filed 24 July 2013 — 24 July 2013Director · Rexford Industrial Realty (NSYE: REXR)2 Form 4 lines · source: SEC Form 4
- Filed 8 March 2011 — 16 May 2012Director · PennyMac Mortgage Investment Trust (PMT)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- returned to the issuer 4,322 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 42 April 2025Stock Option (right to buy) · traded 2 April 2025 · filed 2 April 2025
- returned to the issuer 2,951 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 42 April 2025Restricted Stock Units · traded 2 April 2025 · filed 2 April 2025
- returned to the issuer 48,238 shares of Intra-Cellular TherapiesSEC Form 42 April 2025Common Stock · traded 2 April 2025 · filed 2 April 2025
- returned to the issuer 10,000 shares of Intra-Cellular TherapiesSEC Form 42 April 2025Common Stock · traded 2 April 2025 · filed 2 April 2025
- exercised options over 7,009 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 426 February 2025Stock Option (right to buy) · traded 24 February 2025 · filed 26 February 2025
- exercised options over 7,009 shares of Intra-Cellular TherapiesSEC Form 426 February 2025Common Stock · traded 24 February 2025 · filed 26 February 2025
- was granted 46,207 shares of Alexandria Real Estate EquitiesSEC Form 414 January 2025Common Stock · traded 10 January 2025 · filed 14 January 2025
- returned to the issuer 19,156 shares of Alexandria Real Estate EquitiesSEC Form 43 January 2025Common Stock · traded 31 December 2024 · filed 3 January 2025
- was granted 15,610 shares of Alexandria Real Estate EquitiesSEC Form 43 January 2025Common Stock · traded 2 January 2025 · filed 3 January 2025
- exercised options over 1,567 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 425 June 2024Restricted Stock Units · traded 23 June 2024 · filed 25 June 2024
- exercised options over 1,567 shares of Intra-Cellular TherapiesSEC Form 425 June 2024Common Stock · traded 23 June 2024 · filed 25 June 2024
- was granted 2,951 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 418 June 2024Restricted Stock Units · traded 14 June 2024 · filed 18 June 2024
- was granted 4,322 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 418 June 2024Stock Option (right to buy) · traded 14 June 2024 · filed 18 June 2024
- was granted 45,000 shares of Applied TherapeuticsSEC Form 47 June 2024Common Stock · traded 6 June 2024 · filed 7 June 2024
- returned to the issuer 10,655 shares of Alexandria Real Estate EquitiesSEC Form 42 April 2024Common Stock · traded 29 March 2024 · filed 2 April 2024
- had shares withheld for tax on 5,400 shares of Alexandria Real Estate EquitiesSEC Form 42 April 2024Common Stock · traded 29 March 2024 · filed 2 April 2024
- ▼ sold on the open market 7,500 shares of Alexandria Real Estate EquitiesSEC Form 428 February 2024Common Stock · traded 26 February 2024 · filed 28 February 2024
- exercised options over 20,000 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 427 February 2024Stock Option (right to buy) · traded 26 February 2024 · filed 27 February 2024
- exercised options over 16,757 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 427 February 2024Stock Option (right to buy) · traded 26 February 2024 · filed 27 February 2024
- exercised options over 20,000 shares of Intra-Cellular TherapiesSEC Form 427 February 2024Common Stock · traded 26 February 2024 · filed 27 February 2024
- exercised options over 16,757 shares of Intra-Cellular TherapiesSEC Form 427 February 2024Common Stock · traded 26 February 2024 · filed 27 February 2024
- ▼ sold on the open market 8,371 shares of Intra-Cellular TherapiesSEC Form 427 February 2024Common Stock · traded 26 February 2024 · filed 27 February 2024
- ▼ sold on the open market 17,658 shares of Intra-Cellular TherapiesSEC Form 427 February 2024Common Stock · traded 26 February 2024 · filed 27 February 2024
- ▼ sold on the open market 299 shares of Intra-Cellular TherapiesSEC Form 427 February 2024Common Stock · traded 26 February 2024 · filed 27 February 2024
- was granted 35,064 shares of Alexandria Real Estate EquitiesSEC Form 412 January 2024Common Stock · traded 10 January 2024 · filed 12 January 2024
- was granted 3,000 shares of Alexandria Real Estate EquitiesSEC Form 49 January 2024Common Stock · traded 5 January 2024 · filed 9 January 2024
- was granted 47,620 shares of Alexandria Real Estate EquitiesSEC Form 44 January 2024Common Stock · traded 2 January 2024 · filed 4 January 2024
- ▼ sold on the open market 7,500 shares of Alexandria Real Estate EquitiesSEC Form 410 May 2023Common Stock · traded 8 May 2023 · filed 10 May 2023
- returned to the issuer 6,507 shares of Alexandria Real Estate EquitiesSEC Form 44 April 2023Common Stock · traded 31 March 2023 · filed 4 April 2023
- had shares withheld for tax on 10,015 shares of Alexandria Real Estate EquitiesSEC Form 44 April 2023Common Stock · traded 31 March 2023 · filed 4 April 2023
- ▼ sold on the open market 9,000 shares of Alexandria Real Estate EquitiesSEC Form 49 February 2023Common Stock · traded 7 February 2023 · filed 9 February 2023
- had shares withheld for tax on 5,608 shares of Alexandria Real Estate EquitiesSEC Form 431 January 2023Common Stock · traded 27 January 2023 · filed 31 January 2023
- was granted 24,051 shares of Alexandria Real Estate EquitiesSEC Form 412 January 2023Common Stock · traded 10 January 2023 · filed 12 January 2023
- was granted 42,260 shares of Alexandria Real Estate EquitiesSEC Form 45 January 2023Common Stock · traded 3 January 2023 · filed 5 January 2023
- ▼ sold on the open market 6,500 shares of Alexandria Real Estate EquitiesSEC Form 414 December 2022Common Stock · traded 12 December 2022 · filed 14 December 2022
- ▼ sold on the open market 2,500 shares of Alexandria Real Estate EquitiesSEC Form 47 December 2022Common Stock · traded 5 December 2022 · filed 7 December 2022
- was granted 14,846 shares of Frequency Therapeutics (a derivative holding)SEC Form 419 August 2022Stock Option · traded 17 August 2022 · filed 19 August 2022
- returned to the issuer 14,846 shares of Frequency Therapeutics (a derivative holding)SEC Form 419 August 2022Stock Option · traded 17 August 2022 · filed 19 August 2022
- was granted 14,846 shares of Frequency Therapeutics (a derivative holding)SEC Form 419 August 2022Stock Option · traded 17 August 2022 · filed 19 August 2022
- returned to the issuer 14,846 shares of Frequency Therapeutics (a derivative holding)SEC Form 419 August 2022Stock Option · traded 17 August 2022 · filed 19 August 2022
- was granted 14,846 shares of Frequency Therapeutics (a derivative holding)SEC Form 423 June 2022Stock Option · traded 21 June 2022 · filed 23 June 2022
- was granted 2,500 shares of Alexandria Real Estate EquitiesSEC Form 424 May 2022Common Stock · traded 20 May 2022 · filed 24 May 2022
- was granted 24,560 shares of Alexandria Real Estate EquitiesSEC Form 44 April 2022Common Stock · traded 31 March 2022 · filed 4 April 2022
- was granted 16,869 shares of Alexandria Real Estate EquitiesSEC Form 413 January 2022Common Stock · traded 11 January 2022 · filed 13 January 2022
- ▼ sold on the open market 7,500 shares of Alexandria Real Estate EquitiesSEC Form 411 August 2021Common Stock · traded 9 August 2021 · filed 11 August 2021
- ▼ sold on the open market 5,000 shares of Alexandria Real Estate EquitiesSEC Form 44 August 2021Common Stock · traded 2 August 2021 · filed 4 August 2021
- ▼ sold on the open market 5,000 shares of Alexandria Real Estate EquitiesSEC Form 430 July 2021Common Stock · traded 28 July 2021 · filed 30 July 2021
- ▼ sold on the open market 15,000 shares of Alexandria Real Estate EquitiesSEC Form 430 July 2021Common Stock · traded 29 July 2021 · filed 30 July 2021
- was granted 14,846 shares of Frequency Therapeutics (a derivative holding)SEC Form 421 June 2021Stock Option · traded 17 June 2021 · filed 21 June 2021
- was granted 15,000 shares of MeiraGTx Holdings (a derivative holding)SEC Form 414 June 2021Stock Option (right to buy) · traded 10 June 2021 · filed 14 June 2021
- was granted 15,000 shares of MeiraGTx Holdings (a derivative holding)SEC Form 414 June 2021Restricted Share Units · traded 10 June 2021 · filed 14 June 2021
- ▼ sold on the open market 15,000 shares of Alexandria Real Estate EquitiesSEC Form 45 May 2021Common Stock · traded 3 May 2021 · filed 5 May 2021
- ▼ sold on the open market 5,000 shares of Alexandria Real Estate EquitiesSEC Form 45 May 2021Common Stock · traded 4 May 2021 · filed 5 May 2021
- gave away 25,000 shares of Intra-Cellular TherapiesSEC Form 414 April 2021Common Stock · traded 12 April 2021 · filed 14 April 2021
- was granted 21,310 shares of Alexandria Real Estate EquitiesSEC Form 42 April 2021Common Stock · traded 31 March 2021 · filed 2 April 2021
- had shares withheld for tax on 12,395 shares of Alexandria Real Estate EquitiesSEC Form 42 April 2021Common Stock · traded 31 March 2021 · filed 2 April 2021
- exercised options over 37,116 shares of Frequency TherapeuticsSEC Form 429 March 2021Common Stock · traded 25 March 2021 · filed 29 March 2021
- exercised options over 37,116 shares of Frequency Therapeutics (a derivative holding)SEC Form 429 March 2021Stock Option · traded 25 March 2021 · filed 29 March 2021
- exercised options over 12,882 shares of MeiraGTx Holdings (a derivative holding)SEC Form 417 March 2021Stock Option (right to buy) · traded 15 March 2021 · filed 17 March 2021
- exercised options over 12,882 shares of MeiraGTx HoldingsSEC Form 417 March 2021Ordinary Shares · traded 15 March 2021 · filed 17 March 2021
- exercised options over 20,000 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 44 March 2021Stock Option (right to buy) · traded 2 March 2021 · filed 4 March 2021
- exercised options over 20,000 shares of Intra-Cellular TherapiesSEC Form 44 March 2021Common Stock · traded 2 March 2021 · filed 4 March 2021
- ▼ sold on the open market 15,250 shares of Intra-Cellular TherapiesSEC Form 44 March 2021Common Stock · traded 2 March 2021 · filed 4 March 2021
- was granted 21,251 shares of Alexandria Real Estate EquitiesSEC Form 412 January 2021Common Stock · traded 8 January 2021 · filed 12 January 2021
- ▼ sold on the open market 2,310 shares of Frequency TherapeuticsSEC Form 422 December 2020Common Stock · traded 18 December 2020 · filed 22 December 2020
- ▼ sold on the open market 1,814 shares of Frequency TherapeuticsSEC Form 422 December 2020Common Stock · traded 18 December 2020 · filed 22 December 2020
- ▼ sold on the open market 2,864 shares of Frequency TherapeuticsSEC Form 422 December 2020Common Stock · traded 18 December 2020 · filed 22 December 2020
- ▼ sold on the open market 4,300 shares of Frequency TherapeuticsSEC Form 422 December 2020Common Stock · traded 18 December 2020 · filed 22 December 2020
- ▼ sold on the open market 8,412 shares of Frequency TherapeuticsSEC Form 422 December 2020Common Stock · traded 18 December 2020 · filed 22 December 2020
- ▼ sold on the open market 10,000 shares of Frequency TherapeuticsSEC Form 422 December 2020Common Stock · traded 21 December 2020 · filed 22 December 2020
- ▼ sold on the open market 1,439 shares of Frequency TherapeuticsSEC Form 422 December 2020Common Stock · traded 22 December 2020 · filed 22 December 2020
- ▼ sold on the open market 7,441 shares of Frequency TherapeuticsSEC Form 422 December 2020Common Stock · traded 22 December 2020 · filed 22 December 2020
- ▼ sold on the open market 1,120 shares of Frequency TherapeuticsSEC Form 422 December 2020Common Stock · traded 22 December 2020 · filed 22 December 2020
- ▼ sold on the open market 10,000 shares of Frequency TherapeuticsSEC Form 422 December 2020Common Stock · traded 22 December 2020 · filed 22 December 2020
- gave away 20,000 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 418 December 2020Stock Option (right to buy) · traded 17 December 2020 · filed 18 December 2020
- gave away 20,000 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 418 December 2020Stock Option (right to buy) · traded 17 December 2020 · filed 18 December 2020
- gave away 20,000 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 418 December 2020Stock Option (right to buy) · traded 17 December 2020 · filed 18 December 2020
- gave away 20,000 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 418 December 2020Stock Option (right to buy) · traded 17 December 2020 · filed 18 December 2020
- gave away 28,379 shares of Intra-Cellular TherapiesSEC Form 418 December 2020Common Stock · traded 17 December 2020 · filed 18 December 2020
- gave away 28,379 shares of Intra-Cellular TherapiesSEC Form 418 December 2020Common Stock · traded 17 December 2020 · filed 18 December 2020
- gave away 50,000 shares of Applied TherapeuticsSEC Form 42 November 2020Common Stock · traded 29 October 2020 · filed 2 November 2020
- ▼ sold on the open market 4,000 shares of Alexandria Real Estate EquitiesSEC Form 419 August 2020Common Stock · traded 17 August 2020 · filed 19 August 2020
- ▼ sold on the open market 3,500 shares of Alexandria Real Estate EquitiesSEC Form 419 August 2020Common Stock · traded 17 August 2020 · filed 19 August 2020
- exercised options over 15,459 shares of MeiraGTx Holdings (a derivative holding)SEC Form 412 August 2020Stock Option (right to buy) · traded 10 August 2020 · filed 12 August 2020
- exercised options over 15,459 shares of MeiraGTx HoldingsSEC Form 412 August 2020Ordinary Shares · traded 10 August 2020 · filed 12 August 2020
- ▼ sold on the open market 7,500 shares of MeiraGTx HoldingsSEC Form 412 August 2020Ordinary Shares · traded 11 August 2020 · filed 12 August 2020
- ▼ sold on the open market 7,959 shares of MeiraGTx HoldingsSEC Form 412 August 2020Ordinary Shares · traded 12 August 2020 · filed 12 August 2020
- ▼ sold on the open market 25,000 shares of Alexandria Real Estate EquitiesSEC Form 44 August 2020Common Stock · traded 31 July 2020 · filed 4 August 2020
- ▼ sold on the open market 5,000 shares of Alexandria Real Estate EquitiesSEC Form 44 August 2020Common Stock · traded 31 July 2020 · filed 4 August 2020
- ▼ sold on the open market 5,000 shares of Alexandria Real Estate EquitiesSEC Form 44 August 2020Common Stock · traded 3 August 2020 · filed 4 August 2020
- ▼ sold on the open market 10,000 shares of Alexandria Real Estate EquitiesSEC Form 44 August 2020Common Stock · traded 3 August 2020 · filed 4 August 2020
- was granted 55,555 shares of Frequency TherapeuticsSEC Form 423 July 2020Common Stock · traded 20 July 2020 · filed 23 July 2020
- ▲ bought on the open market 55,555 shares of Frequency TherapeuticsSEC Form 422 July 2020Common Stock · traded 20 July 2020 · filed 22 July 2020
- gave away 20,000 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 410 July 2020Stock Option (right to buy) · traded 8 July 2020 · filed 10 July 2020
- exercised options over 14,005 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 426 June 2020Restricted Stock Units · traded 25 June 2020 · filed 26 June 2020
- exercised options over 14,005 shares of Intra-Cellular TherapiesSEC Form 426 June 2020Common Stock · traded 25 June 2020 · filed 26 June 2020
- was granted 14,846 shares of Frequency Therapeutics (a derivative holding)SEC Form 412 June 2020Stock Option · traded 11 June 2020 · filed 12 June 2020
- ▼ sold on the open market 10,000 shares of Alexandria Real Estate EquitiesSEC Form 49 June 2020Common Stock · traded 5 June 2020 · filed 9 June 2020
- ▼ sold on the open market 15,000 shares of Alexandria Real Estate EquitiesSEC Form 49 June 2020Common Stock · traded 5 June 2020 · filed 9 June 2020
- was granted 10,230 shares of Applied Therapeutics (a derivative holding)SEC Form 45 June 2020Stock Option (Right to Buy) · traded 4 June 2020 · filed 5 June 2020
- was granted 25,000 shares of MeiraGTx Holdings (a derivative holding)SEC Form 44 June 2020Stock Option (right to buy) · traded 2 June 2020 · filed 4 June 2020
- was granted 13,767 shares of Intra-Cellular Therapies (a derivative holding)SEC Form 428 May 2020Restricted Stock Units · traded 27 May 2020 · filed 28 May 2020
- ▼ sold on the open market 5,000 shares of Frequency TherapeuticsSEC Form 422 May 2020Common Stock · traded 21 May 2020 · filed 22 May 2020
- ▼ sold on the open market 15,000 shares of Frequency TherapeuticsSEC Form 420 May 2020Common Stock · traded 18 May 2020 · filed 20 May 2020
- ▼ sold on the open market 7,809 shares of Frequency TherapeuticsSEC Form 420 May 2020Common Stock · traded 19 May 2020 · filed 20 May 2020
- ▼ sold on the open market 5,000 shares of Frequency TherapeuticsSEC Form 420 May 2020Common Stock · traded 20 May 2020 · filed 20 May 2020
- ▼ sold on the open market 9,602 shares of Intra-Cellular TherapiesSEC Form 415 May 2020Common Stock · traded 14 May 2020 · filed 15 May 2020
- ▼ sold on the open market 10,764 shares of Applied TherapeuticsSEC Form 415 May 2020Common Stock · traded 13 May 2020 · filed 15 May 2020
- ▼ sold on the open market 5,905 shares of Applied TherapeuticsSEC Form 415 May 2020Common Stock · traded 13 May 2020 · filed 15 May 2020
- ▼ sold on the open market 500 shares of Applied TherapeuticsSEC Form 415 May 2020Common Stock · traded 13 May 2020 · filed 15 May 2020
- ▼ sold on the open market 2,012 shares of Applied TherapeuticsSEC Form 415 May 2020Common Stock · traded 13 May 2020 · filed 15 May 2020
- ▼ sold on the open market 1,600 shares of Applied TherapeuticsSEC Form 415 May 2020Common Stock · traded 13 May 2020 · filed 15 May 2020
- ▼ sold on the open market 2,202 shares of Applied TherapeuticsSEC Form 415 May 2020Common Stock · traded 13 May 2020 · filed 15 May 2020
- ▼ sold on the open market 2,017 shares of Applied TherapeuticsSEC Form 415 May 2020Common Stock · traded 13 May 2020 · filed 15 May 2020
- ▼ sold on the open market 9,177 shares of Applied TherapeuticsSEC Form 415 May 2020Common Stock · traded 14 May 2020 · filed 15 May 2020
- ▼ sold on the open market 5,723 shares of Applied TherapeuticsSEC Form 415 May 2020Common Stock · traded 15 May 2020 · filed 15 May 2020
- ▼ sold on the open market 100 shares of Applied TherapeuticsSEC Form 415 May 2020Common Stock · traded 15 May 2020 · filed 15 May 2020
- ▼ sold on the open market 4,900 shares of MeiraGTx HoldingsSEC Form 414 May 2020Ordinary Shares · traded 12 May 2020 · filed 14 May 2020
- ▼ sold on the open market 22 shares of MeiraGTx HoldingsSEC Form 414 May 2020Ordinary Shares · traded 12 May 2020 · filed 14 May 2020
- ▼ sold on the open market 7,297 shares of Intra-Cellular TherapiesSEC Form 413 May 2020Common Stock · traded 13 May 2020 · filed 13 May 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.